Market revenue in 2023 | USD 137.0 million |
Market revenue in 2030 | USD 199.1 million |
Growth rate | 5.5% (CAGR from 2023 to 2030) |
Largest segment | Frozen nondonor |
Fastest growing segment | Frozen Nondonor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.32% in 2023. Horizon Databook has segmented the South Africa in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
Infertility is a significant global issue, affecting a large number of couples worldwide. The fertility rate for South Africa in 2023, as reported by microtrends.net, stands at 2.309 births per woman, indicating a 0.9% decrease compared to the previous year, 2022. In addition, according to estimates, approximately 48.5 million couples experience infertility globally.
The prevalence of infertility varies across different regions and countries, with higher rates often observed in Low- and Middle-income Countries (LMIC) and specific regions, such as Sub-Saharan Africa. Sub-Saharan Africa, in particular, has reported some of the highest rates of infertility worldwide.
Estimates suggest that infertility prevalence in this region can reach as high as 30% to 40%. Several factors contribute to the higher rates, including limited access to healthcare services, lack of reproductive health education, prevalent infectious diseases (such as STDs), cultural & societal factors, and inadequate funding for infertility treatments.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into South Africa in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account